Enhanced transgene expression and effective in vivo antitumor immune responses initiated by dendritic progenitors transfected with a nonviral T7 vector expressing a model tumor antigen

Journal of Immunotherapy

Volumn 23, Issue 1, 2000, Pages 75-82

  Wei, Yanzhang ^a,b   Li, Jinhua ^a   Chen, Wen Y ^a,b   Yu, Xianzhong ^a   Sticca, Robert P ^a   Wagner, Thomas E ^a,b  

^a GREENVILLE HOSPITAL SYSTEM   (United States)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

Dendritic progenitor; Immunotherapy; Luciferase; T7 vector; Transfection; Tumor

Indexed keywords

LUCIFERASE; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL MATURATION; DENDRITIC CELL; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TRANSGENE; TUMOR;

ANIMALS; ANTIGENS, NEOPLASM; BONE MARROW CELLS; CELL DIFFERENTIATION; DENDRITIC CELLS; DNA-DIRECTED RNA POLYMERASES; FEMALE; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; LUCIFERASES; MICE; MICE, INBRED C57BL; MODELS, IMMUNOLOGICAL; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TRANSGENES; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 0033960412     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200001000-00010     Document Type: Article

References (31)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
2. Inaba K, Metlay JP, Crowley MT, Steinman RM. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 1990;172:631-40.
3. Gong J, Chen D, Kashiwaba M, Kufe D. Induction of anti-tumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 1997;3:558-61.
4. Hsu FJ, Benike C, Fagnoni F, Liles TM, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52-8.
5. Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP. Dendritic cells in anti-tumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cell Immunol 1996;170:111-19.
6. Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic anti-tumor immunity. Nat Med 1995;1:1297-1302.
7. Tao MH, Levy R. Idotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 1993;362:755-8.
8. Alijagic S, Moller P, Artuc M, Czarnetzki BM, Schadendorf K. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 1995;25:3100-7.
9. + dendritic cells. Proc Natl Acad Sci USA 1996;93:2588-92.
10. Romani N, Reider D, Heuer M, et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J Immunol Meth 1996;196:137-51.
11. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Meth 1996;196: 121-35.
12. + human blood dendritic cells for active tumor immunotherapy. Exp Hematol 1997;25:232-7.
13. Chapuis F, Rosenzwajg M, Yagello M, et al. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997;27:431-41.
14. + hematopoietic precursor cells. Blood 1996;87:535-44.
15. Saunders D, Lucas K, Ismaili J, et al. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J Exp Med 1996;184: 2185-96.
16. Xu S, Ariizum K, Caceres-Dittmar G, et al. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J Immunol 1995;154:2697-2705.
17. Ruedl C, Rieser C, Bock G, Wick G, Wolf H. Phenotypic and functional characterization of CD11C dendritic cell population in mouse payer's patches. Eur J Immunol 1996;26:1801-6.
18. Shurin MR. Dendritic cells presenting tumor antigen. Cancer Immunol Immunother 1996;43:158-64.
19. Paglia P, Chiodoni C, Rodolfo M, Colombo MP. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 1996;183:317-22.
20. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
21. Ribas A, Butterfield LH, McBride WH, et al. Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res 1997;57:2865-9.
22. Dietz AB, Vuk-Pavlovic S. High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 1998;91:392-8.
23. Reeves ME, Royal RE, Lam JS, Rosenberg SA, Hwu P. Retroviral transduction of human dendritic cells with tumor-associated antigen gene. Cancer Res 1996;56:5672-7.
24. Tuting T, DeLeo AB, Lotze MT, Stokus WJ. Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or self antigens induce anti-tumor immunity in vivo. Eur J Immunol 1997;27:2702-7.
25. McArthur JG, Mulligan RC. Induction of protective anti-tumor immunity by gene modified dendritic cells. J Immunotherapy 1998;21:41-7.
26. Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996;184:465-72.
27. Chen X, Li Y, Xiong K, Wagner TE. A self-initiating eukaryotic transient gene expression system based on cotransfection of bacteriophage T7 RNA polymerase and DNA vectors containing a T7 autogene. Nucleic Acids Res 1994;22:2114-20.
28. Chen X, Li Y, Xiong K, et al. A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy. Cancer Gene Ther 1995;2:281-9.
29. Chen X, Li Y, Xiong K, et al. Cancer gene therapy by direct tumor injections of a nonviral T7 vector encoding a thymidine kinase gene. Hum Gene Ther 1998;9:729-36.
30. Mandl CW, Aberle JH, Aberle SW, et al. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flaviviurs model. Nat Med 1998;4:1438-40.
31. Morse MA, Lyerly HK, Gilboa E, Thomas E, Nair SK. Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells. Cancer Res 1998;58:2965-8.